033sek
-7,3 %
Date:2024-05-03Time:13:46:35Latest report:Q1-2024List:First NorthTicker:SPAGO
Market Cap:75 msekEnterprise Value:42 msekNet Sales:1,47 msekEarnings:-32,2 msekEmployees:0ISIN:SE0004899474

Ratios

10-year key figure history for Spago Nanomedical turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Spago Nanomedical with index and moving average MA50 and MA200.

Stockprice:0,33
MA50:0,30
MA200:0,33
Price/MA200:-0,5 %
RSI (14):56,4
Price/MA50:9,3 %

Description

Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Biotechnology